Results showed that the expression levels of OLR1 and HHIP genes in NSCLC were much higher than in other cancer types (Figure S2), indicating that these two genes could serve as specific biomarkers in NSCLC progression. This evidence concerns the gene HHIP and non-small cell lung carcinoma.